Nanotechnology promises ways to deliver cancer-killing drugs or imaging agents directly to diseased cells. But cell-targeting nanoparticles will need a way to get through the cell’s main line of defense against foreign entities: its membrane. While some nanoparticles can enter by poking holes in the membrane, that can destroy the cell.

Now a group at MIT has created the first synthetic nanoparticles that are large enough to hold drugs or imaging agents but can still slip through cells’ membranes without breaking them. The researchers’ breakthrough was to coat gold nanoparticles with alternating bands of hydrophobic and hydrophilic molecules.
The idea sprang from a conversation between Darrell Irvine, associate professor of biological engineering, and Francesco Stellacci, associate professor of materials science and engineering. Stellacci mentioned that nanoscale mixtures of hydrophilic and hydrophobic materials naturally separate into stripes. Irvine suggested that they test how particles coated with such stripes interact with cell membranes, which are made up of hydrophobic and hydrophilic layers.
In research reported in Nature Materials in May, Irvine, Stellacci, and their colleagues described how their striped nanoparticles, which were 10 to 12 nanometers in diameter and carried fluorescent dye, successfully penetrated mouse cells without rupturing them. Nanoparticles coated randomly with the same hydrophobic and hydrophilic material could not penetrate the cells.
“That this was dependent on the structure of the chemical groups on the surface of the particle rather than some other property was a major, unexpected finding,” says Irvine.
The team plans to explore what cargo the particles can successfully carry and whether striped nanoparticles made of materials other than gold have the same properties.
Keep Reading
Most Popular
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.